Details - Clinical Research

Clinical Research Details

Back to List

Descriptive Information

Title

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.

Investigator Name

Roland Kaddoum

rk16@aub.edu.lb

Protocol Id

NCT 02375217

Status

Completed- Has Results

Study Type

Translational Research - Cost Effectiveness Research

Phase

Looking for Med Students Volunteers

Coordinators

Arwa Bou Ali

ab54@aub.edu.lb

Extension: 6346

Conditions and Keywords

Conditions

Effect of Half dose sugammadex combined with neostigmine

Keywords

Neuromuscular blockade; Rocuronium; Sugammadex

Study Design

Eligibility and IRB

Gender

Both

Age Limits

Min:

Max:

IRB Approval

Yes

Healthy Volunteer

Study Description

Population Description

Sampling Method

Inclusion Criteria

Exclusion Criteria

Back to List